Investment Pitches

Pitch Summary:
@Pelicanwayre presents a bearish investigation into AZ, alleging that the company’s reported smart cart orders are largely fictitious, overstated, or routed through undercapitalized middlemen. The thread challenges the credibility of multiple announced customers by examining public filings, site visits, and customer disclosures that suggest minimal delivery and limited end-market adoption. Revenue concentration appears extreme, with nearly all historical smart cart revenue tied to a single customer. The pitch further argues that follow-on orders from AZ’s largest client have not materialized despite company claims. Governance concerns are central to the thesis, highlighting management and board members with histories tied to failed penny stocks and inconsistent disclosures. The overall conclusion is that AZ’s reported backlog and growth narrative are not supported by observable evidence.

BSD Analysis:
This case hinges on revenue quality and management credibility rather than product potential. In retail technology, adoption risk is already high due to long sales cycles, retailer conservatism, and the need for proven ROI; overstating deployments meaningfully undermines trust with customers and capital markets alike. If true deliveries are concentrated in a single customer with stalled expansion, the implied total addressable market penetration collapses, and prior order announcements lose informational value. Industry structure favors well-capitalized vendors with reference customers and repeatable rollouts, leaving little tolerance for execution gaps or intermediary-heavy “sales.” Governance risk compounds the issue: serial penny-stock management teams with opaque disclosures materially raise the discount rate investors apply to all forward-looking claims. Even generous assumptions about eventual smart cart adoption would not justify valuation if commercialization is neither verifiable nor scalable. Absent clear evidence of fulfilled orders, reputable customers, and stable leadership, downside is driven less by competition and more by the erosion of credibility itself.

Actual Post Content:
$AZ's client list appears bolstered with middlemen and bizarre customers. Hex 1011, one of $AZ's earlier clients, purportedly ordered approximately 20,000 carts worth roughly $160mm. However, their website identifies them as a cybersecurity firm based in Thailand with no mention of $AZ in their partner section. Thailand DBD filings reveal the company has just $9,200 in assets, nowhere near enough to support an order of that magnitude. The rest of the clients are not much better, with $AZ claiming they entered a $25mm, 3,000 cart deal with Trixo Group to enter LATAM. No retailers were named; Trixo is just a point-of-sale company, a glorified middleman. Morton Williams is an NYC grocery chain, had ordered a few hundred carts. We called and visited Morton Williams locations across NYC, and only the West End location had any, which was their test site. The failures to deliver don’t just stop in LATAM and the US. In France, $AZ announced a 30,000 cart deal via IR2S. Why would their latest order for 3,000 carts be any different? Despite $AZ claiming approximately 52,000 carts in orders beyond Yochananof, we believe $AZ has delivered only 37 of them. Yochananof's 1,300-cart order appears fully delivered according to their FY24 report at roughly $8,300 per cart, accounting for approximately $10.8mm of the $11.1mm in total smart cart revenue since 2021. But they have even disappointed their biggest customer, the purported follow-up order of 1,700 carts from Yochananof does not appear to have been fulfilled. $AZ’s management is a revolving door of penny stock alumni. Chairman and former CEO Joseph Bentsur was formerly president of the failed Inrob Tech, which was delisted, and four hedge funds associated with the company, along with the general counsel, have reportedly had major run-ins ins the SEC. Bentsur maintains at least three separate LinkedIn accounts we could find, each with its own separate telling of his career, with one even claiming that $AZ was sold to an arm of Disney. Current CFO Alan Rootenberg has been the CFO at many failed penny stocks, most of which have been in totally unrelated sectors like healthcare, mining, etc. The description of Rootenburg in the FY24 annual report leaves out a whopping 74% of his past endeavors. Now, past returns are not always indicative of future results, but we’re pretty sure we know how this plays out. Finally, former CFO Gadi Levin completely omits his time at $AZ from his LinkedIn, while keeping multiple penny stocks he worked at on the page. Shareholders should ask themselves why the former CFO would rather be associated with penny stocks rather than $AZ…

URL: https://x.com/Pelicanwayre/status/1995871209112621100

Pitch Summary:
The pitch frames nLIGHT (LASR) as a compelling way to benefit from increasing global militarization, describing it as a “picks & shovels” supplier that provides the underlying high-power laser technology used across multiple defense programs. The author explains that the company has deliberately shifted away from lower-margin industrial welding and other commodity commercial laser applications, instead repositioning itself heavily toward aerospace and defense. This pivot is supported by the company’s growing involvement in long-duration defense programs, many of which depend on LASR’s laser modules or subsystems.

BSD Analysis:
nLIGHT (LASR) is framed as a “picks & shovels” beneficiary of rising defense spending, having shifted from low-margin industrial welding lasers to high-power systems for directed-energy, counter-UAS, and military-grade optics; once LASR’s tech is designed into a platform it becomes “extremely sticky,” driving multi-year revenue visibility and a growing, higher-margin backlog. EDU.AX, meanwhile, delivered what the author calls a “banger announcement,” raising FY25 guidance and launching a 13% buyback at 55c—an accretive repurchase priced at roughly 5.5× forward EPS. The guidance lift implies stronger incremental profitability than management had signaled, making “$20mm NPAT next yr… well in play,” and the reduced share count boosts EPS from ~13c to ~15.7c. Even after the move, the author argues shares remain “<6x EPS,” with excess cash, a cleaned-up register, and room for valuation to expand from ~3.1× EV/EBITDA toward levels that would support a 90c–$1 share price. He expects another large buyback within 12 months and sees the setup as one that could deliver rerating plus a high single-digit dividend yield.

Actual Post Content:
nLIGHT (LASR) is described as a “picks & shovels” play on militarization, having shifted from low-margin industrial welding lasers to high-power systems used in defense applications such as directed-energy, counter-UAS, and military-grade optics. The author emphasizes that once LASR’s technology is integrated into a defense platform, it becomes “extremely sticky,” creating multi-year revenue visibility and contributing to a backlog with an improving margin profile. Separately, EDU.AX is highlighted for a major update that lifted FY25 guidance and included a 13% buyback at 55c, which the author calls a “banger announcement.” He views the guidance raise as evidence that incremental profitability is stronger than management had previously indicated, making “$20mm NPAT next yr… well in play.” The buyback is considered highly accretive, with shares retired at roughly 5.5x forward EPS, implying management sees clear value. On his numbers, EPS increases from 13c to 15.7c next year due to the reduced share count. He argues the stock remains cheap at “<6x EPS,” noting that EDU.AX still has substantial excess cash and few natural sellers after the register cleanup. Before the buyback, it traded at 3.1x EV/EBITDA, and even a one-turn expansion supports valuations in the 90c range. He concludes that another large repurchase is likely within a year and expects the stock to rerate toward 90c–$1 while offering a high single-digit dividend yield.

URL: https://x.com/KairosPraxis/status/1995946113594241113

Pitch Summary:
Expedia has shown significant outperformance in the travel sector, with shares rising over 40% this year. Despite recent gains, it remains undervalued compared to peers, offering a compelling investment opportunity as it continues to trade at a discount. The company's One Key rewards program and strong booking growth position it well for continued success.

BSD Analysis:
Expedia's strategic investments in its One Key rewards program are beginning to yield results, driving market share gains and enhancing customer loyalty. The company's diverse supply across its platforms, including Expedia.com, Hotels.com, and Vrbo, provides a competitive edge. Despite a challenging macroeconomic environment, Expedia's bookings growth has accelerated, outpacing its main competitor, Booking Holdings. The company's valuation remains attractive, trading at a significant discount to peers like Booking and Airbnb, even as it closes the gap in bookings growth. With a strong EBITDA margin and a focus on promotional deals, Expedia is well-positioned to capitalize on a value-conscious consumer base.

Pitch Summary:
Palantir Technologies is currently undervalued following a 20% dip in its stock price, despite strong fundamentals and growth potential. The company has consistently beaten earnings expectations and is projected to maintain a 20%+ revenue growth rate until at least FY2034. With a robust growth strategy that includes expanding its customer base and product offerings, Palantir is well-positioned to capitalize on AI-driven opportunities.

BSD Analysis:
Palantir's recent 20% stock price decline is seen as unjustified given the company's strong earnings revisions and consistent performance in exceeding market expectations. The company has a diverse growth strategy, acquiring new customers and expanding its use cases, which currently stand at 175. Despite a high P/E ratio of 231, the expected contraction of this ratio over the next few years supports a bullish outlook. Palantir's partnerships, such as those with Saildrone and FTAI Aviation, further enhance its market potential. While insider selling and profit-taking by investors pose risks, the company's strong fundamentals and growth trajectory make it a compelling investment.

Pitch Summary:
Massimo Group has shown a recovery in operating income and gross margins in Q3 2025 after facing significant challenges earlier in the year due to tariffs and retailer destocking. Despite this recovery, the company's valuation appears high given its customer concentration and limited profitability.

BSD Analysis:
Massimo Group's recent financial results indicate a positive trend in revenue and profitability, with a notable improvement in gross margins. However, the company's reliance on a single major customer poses a significant risk, as any changes in this customer's demand could heavily impact Massimo's revenues. The company's current market capitalization of $185 million seems difficult to justify, especially considering its past performance and the challenges it faces, such as tariffs and a thin balance sheet. While there is potential for further recovery, the company's valuation remains a concern, and a conservative approach is warranted. The upside risk includes continued positive results and fixed operating expenses, which could lead to rapid earnings recovery and stock appreciation.

Pitch Summary:
Home Bancshares, Inc. is showing signs of improvement in its financial health, with rising net interest margins and profitability. Despite a recent dip in stock price, the company's asset quality remains strong, and its valuation has become more attractive, warranting a soft 'Buy' rating.

BSD Analysis:
Home Bancshares has demonstrated resilience with a rise in net interest margin from 4.28% to 4.56% over the past year, driven by strategic balance sheet adjustments and favorable interest rate conditions. The bank has managed to reduce its debt levels significantly while maintaining a diverse loan portfolio, which includes commercial real estate and residential mortgages. Although deposits have seen a decline, this is attributed to seasonal fluctuations and a reduction in brokered deposits. The company's non-interest income has also increased, contributing to higher net profits. With a return on assets of 2.17% and a return on equity of 11.91%, Home Bancshares is outperforming many of its peers, making it a compelling investment opportunity.

Pitch Summary:
AMD is positioned to gain market share in the AI chip industry by offering a cost-effective alternative to Nvidia. The company's ROCm platform provides a flexible and scalable solution, and AMD aims to increase its data center GPU market share significantly.

BSD Analysis:
AMD has been growing its market share in data center GPUs, albeit from a smaller base compared to Nvidia. The company's strategic focus on providing a cheaper alternative to Nvidia's offerings could help it capture more market share, especially as buyers use AMD as leverage in negotiations. AMD's growth strategy is supported by its recent financial performance, with expectations of accelerating revenue growth driven by major AI deals. However, execution risks remain, and the company must navigate competition from both established players and new entrants.

Pitch Summary:
Nvidia is at the forefront of the AI revolution, with its GPUs being critical for AI applications. The company has shown strong financial performance, with significant revenue and earnings beats, and maintains a dominant market share in data center GPUs.

BSD Analysis:
Nvidia's strong financial performance is highlighted by its impressive gross margins of 73.6%, which are comparable to software companies. Despite the high P/E ratio, Nvidia's leadership position and growth prospects suggest that the stock is undervalued. However, the company faces risks from potential competitors like Alphabet's TPU chips and geopolitical factors such as export controls. Nvidia's continued innovation and execution in introducing new chip versions faster than industry norms are key to maintaining its competitive edge.

Pitch Summary:
Kura Oncology is positioned as a strong buy due to the potential of its drug Ziftomenib (Komzifti) to capture significant market share in the treatment of relapsed/refractory NPM1-mutated acute myeloid leukemia (AML). The drug's differentiation from competitors, particularly Syndax's Revuforj, is highlighted by its lower cardiac risk profile, which could enable Kura to gain an edge despite Syndax's first-mover advantage.

BSD Analysis:
Kura's Ziftomenib has been approved by the FDA for treating relapsed/refractory NPM1-mutated AML, a market estimated at $400 million in the US. However, the real opportunity lies in the front-line AML market, potentially worth $3 billion to $7 billion. Kura's partnership with Kyowa Kirin financially derisks the company, but execution in the larger front-line market is crucial for massive returns. While Syndax's Revuforj has shown strong efficacy data, its cardiac risks could be a disadvantage. Kura's upcoming data presentations at the ASH 2025 Annual Meeting could further validate its position if efficacy results align with Syndax's high standards.

Pitch Summary:
Caleres, Inc. is facing significant challenges due to its acquisition of Stuart Weitzman, which has added debt and unprofitable operations to its balance sheet. The company is experiencing declining sales, margin pressure, and increased leverage, making it a risky investment.

BSD Analysis:
Caleres has a long history in the footwear industry, but its recent acquisition of Stuart Weitzman has introduced substantial financial risks. The company's sales have been stagnant over the past decade, and recent performance has been weak, with sales and earnings declining. The acquisition has increased the company's net debt significantly, and the added losses from Stuart Weitzman are further straining its financials. Despite some recovery in share price, the overall outlook remains uncertain, with no immediate signs of improvement in operating performance or debt levels. The combination of these factors suggests a cautious approach to investing in Caleres at this time.

Pitch Summary:
JEPI is positioned as a defensive investment with a strategy that involves selling call options against the S&P 500 to generate income. Despite its recent outperformance during market corrections, it is expected to underperform in a bull market due to its defensive nature and lack of exposure to growth sectors.

BSD Analysis:
JEPI's strategy of selling covered calls against the S&P 500 while holding a defensive basket of stocks creates a pair-trade that is long quality stocks and short the index. This approach may limit upside potential, especially if growth stocks continue to outperform. The fund's use of equity-linked notes (ELNs) for income generation is not tax-efficient compared to competitors using FLEX options, which offer tax advantages. JEPI's sector allocation is less concentrated in technology compared to the S&P 500, which may hinder performance if technology stocks continue to drive market gains. While JEPI provides a high yield, its total return may lag behind more aggressive strategies that capture growth opportunities.

Pitch Summary:
Concentrix Corporation is poised for a turnaround with an expected earnings inflection point in FY26, driven by its strategic integration of AI and human intelligence in customer experience solutions. Despite recent earnings declines and a significant drop in stock price, the company offers a compelling valuation at 2.95 times FY26E non-GAAP EPS and a 3.9% dividend yield.

BSD Analysis:
Concentrix has faced challenges with declining earnings over the past three years due to high R&D spending on AI and increased interest expenses from acquisitions. However, the company's strategic focus on combining AI with human intelligence in its services is anticipated to drive a recovery in earnings starting FY26. The recent insider buying by top executives suggests confidence in this turnaround. With a strong client base, including many Fortune 500 companies, and a significant market presence, Concentrix is well-positioned to capitalize on the growing CX BPO market. The stock's current low valuation and dividend yield make it an attractive investment for those willing to take on some risk for potential upside.

Pitch Summary:
@puppyeh1 is bullish on EDU Holdings (EDU.AX) after a guidance upgrade and a large selective buyback executed at what he views as a very low earnings multiple. He argues the raised FY25 outlook signals stronger incremental profitability than management had previously implied, supporting the idea that roughly A$20m of NPAT is achievable in the next year. The buyback is framed as highly accretive, materially lifting per-share earnings power by shrinking the share count at a depressed valuation. He contends the company should still retain significant excess cash even after the repurchase, implying additional capital return capacity. A second-order catalyst is the removal of a selling overhang as major holders reduce stakes, improving technicals and scarcity value. He lays out a re-rating path where modest multiple expansion and/or continued buybacks drive the stock toward a materially higher price band. Key risks embedded in the setup are whether the upgraded guidance proves durable and whether management can continue compounding earnings while balancing buybacks and dividends.

BSD Analysis:
This is a classic small-cap “capital allocation + de-risking” pitch: when a business with improving earnings trajectory retires stock aggressively at low multiples, per-share compounding can accelerate even without heroic top-line assumptions. The central diligence items are quality and sustainability of earnings (enrolment trends, pricing, regulatory exposure, and cost cadence), plus working-capital dynamics that can distort near-term cash conversion in education providers. Buybacks are only value-creative if underlying margins are defendable and the balance sheet remains resilient through demand shocks; otherwise they can be pro-cyclical. The “overhang removal” point matters in micro-caps, but the durable re-rate typically requires repeatable disclosure of earnings power and credible reinvestment/return framework, not just a one-off transaction. Valuation framing should explicitly separate operating earnings from surplus cash, because excess cash can mask weaker underlying returns if not deployed rationally. If management continues to retire shares while maintaining disciplined reinvestment in student acquisition and delivery quality, the equity can re-rate toward peer multiples for education services. Conversely, if the guidance upgrade is driven by timing/one-offs or if regulatory/visa settings shift against international intake, the market will discount the multiple quickly. The cleanest confirmation will be follow-through in FY25 results and evidence that the margin structure holds as the growth mix evolves.

Actual Post Content:
$EDU.AX out w/ banger announcement, lifting FY25 guidance substantially - to inline w/ my nos - along w/ 13% buyback from Mulpha @ 55c/share. https://hotcopper.com.au/threads/ann-fy25-guidance-upgrade-selective-buy-back-initiative.8915047/#post-81880978 A fair few implications... guidance raise. Not hugely surprising to me, but further evidence incremental profits higher again than mgmt was letting on. Despite timing on costs, expect margins to be at a min maintained next yr given this...ie $20mm NPAT next yr is clearly well in play. EPS accretion. They are acquiring 13% of the co at ~5.5x EPS (on FY25 nos, not adjusted for excess cash). Gives you a sense where they think value is. If my FY26 nos are accurate (ie $20mm NPAT, etc), EPS next yr goes from 13c to 15.7c thru this... Valuation. Still will have boatloads of excess cash post this and (I guess) no more, or few, natural sellers. Seemingly they see tons of value at <6x EPS straight up. 6x EPS on FY26 now - no credit for cash at all - is 80c...would argue they will continue to buy stock up to that level (assuming they can) as we head thru next year... Realistically they should get more credit for moves like this - keep in mind they have no retired ~17% of the co in a single year here. Before this move it traded at 3.1x EV/EBITDA. One turn expansion - not a huge amount - puts you at 94c on my numbers next yr... Overhang removed. Where is the incremental seller after this? Investec is basically out. Mulpha down to near 5% (assume they exit next six mos). Otherwise mgmt collectively owns 23% and have only added over last yr. This transaction is essentially another way to add exposure... so yes assuming no major rerating I expect another one of these large accretive buybacks, prob within a year. More likely is you get your high single digit divyield out of FY25 earnings and the stock rerates to 90c-$1 before that, however. Mgmt is to be applauded. GLTA. DYODD.

URL: https://x.com/puppyeh1/status/1995393948341109056

Pitch Summary:
@puppyeh1 highlights a “banger announcement” from $EDU.AX, noting that FY25 guidance was raised to align with his expectations and paired with a 13% buyback at 55c. He sees the guidance increase as confirmation that incremental profitability is stronger than management had suggested, making “$20mm NPAT next yr… clearly well in play.” The buyback is viewed as highly accretive since the company is acquiring 13% of shares at roughly 5.5x EPS, a level he believes signals management’s conviction about intrinsic value. Based on his FY26 numbers, EPS would rise from 13c to 15.7c due solely to the reduced share count. The stock still holds substantial excess cash and trades at “<6x EPS,” which he argues is too cheap given the company’s financial trajectory. He notes the float has shrunk dramatically—“~17% of the co in a single year”—and even a modest re-rating from 3.1x to 4.1x EV/EBITDA supports valuations near 94c. With major sellers like Investec essentially gone and Mulpha likely exiting soon, he sees the overhang removed and expects another accretive buyback within a year. Ultimately, he anticipates the stock delivering a high single-digit dividend yield and re-rating toward 90c–$1 ahead of additional buybacks.

BSD Analysis:
nan

Actual Post Content:
$EDU.AX out w/ banger announcement, lifting FY25 guidance substantially — to inline w/ my nos ☺️ — along w/ 13% buyback from Mulpha @ 55c/share. 1) guidance raise. Not hugely surprising to me, but further evidence incremental profits higher again than mgmt was letting on. Despite timing on costs, expect margins to be at a min maintained next yr given this… ie $20mm NPAT next yr is clearly well in play. 2) EPS accretion. They are acquiring 13% of the co at ~5.5x EPS (on FY25 nos, not adjusted for excess cash). Gives you a sense where they think value is. If my FY26 nos are accurate (ie $20mm NPAT, etc), EPS next yr goes from 13c to 15.7c thru this. 3) Valuation. Still will have boatloads of excess cash post this and (I guess) no more, or few, natural sellers. Seemingly they see tons of value at <6x EPS straight up. 6x EPS on FY26 now — no credit for cash at all — is 80c… would argue they will continue to buy stock up to that level (assuming they can) as we head thru next year… Realistically they should get more credit for moves like this — keep in mind they have now retired ~17% of the co in a single year here. Before this move it traded at 3.1x EV/EBITDA. One turn expansion — not a huge amount — puts you at 94c on my numbers next yr… 4) Overhang removed. Where is the incremental seller after this? Investec is basically out. Mulpha down to near 5% (assume they exit next six mos). Otherwise mgmt collectively owns 23% and have only added over last yr. This transaction is essentially another way to add exposure… … so yes assuming no major rerating I expect another one of these large accretive buybacks, prob within a year. More likely is you get your high single digit divyield out of FY25 earnings and the stock rerates to 90c–$1 before that, however. Mgmt is to be applauded. GLTA. DYODD. ✊✊

URL: https://x.com/puppyeh1/status/1995393936651850024